In less than a week’s time, families around the country will be sitting down to tuck into their traditional Christmas dinner.
ASCO 2024: MSD’s ADC shows efficacy in lung and breast tumours
Sacituzumab tirumotecan is a trophoblast cell-surface antigen 2 (TROP2) targeting antibody linked to linked to a belotecan-derivative topoisomerase I inhibitor payload. Image Credit: testing /